Literature DB >> 26662040

ADIPOR1 Is Mutated in Syndromic Retinitis Pigmentosa.

Mingchu Xu1,2, Aiden Eblimit1,2, Jing Wang1, Jianli Li1, Feng Wang1,2, Li Zhao1,2,3, Xia Wang1, Ningna Xiao1,2, Yumei Li1,2, Lee-Jun C Wong1, Richard A Lewis1,4, Rui Chen1,2,3,5,6.   

Abstract

Retinitis pigmentosa (RP) is a genetically heterogeneous retinal disorder. Despite the numerous genes associated with RP already identified, the genetic basis remains unknown in a substantial number of patients and families. In this study, we performed whole-exome sequencing to investigate the molecular basis of a syndromic RP case that cannot be solved by mutations in known disease-causing genes. After applying a series of variant filtering strategies, we identified an apparently homozygous frameshift mutation, c.31delC (p.Q11Rfs*24) in the ADIPOR1 gene. The reported phenotypes of Adipor1-null mice contain retinal dystrophy, obesity, and behavioral abnormalities, which highly mimic those in the syndromic RP patient. We further confirmed ADIPOR1 retina expression by immunohistochemistry. Our results established ADIPOR1 as a novel disease-causing gene for syndromic RP and highlight the importance of fatty acid transport in the retina.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  ADIPOR1; fatty acid; next-generation sequencing; obesity; retina

Mesh:

Substances:

Year:  2016        PMID: 26662040      PMCID: PMC5383450          DOI: 10.1002/humu.22940

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

1.  Prediction of translation initiation sites in human mRNA sequences with AUG start codon in weak Kozak context: A neural network approach.

Authors:  Suhas Tikole; Ramasubbu Sankararamakrishnan
Journal:  Biochem Biophys Res Commun       Date:  2008-03-13       Impact factor: 3.575

2.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.

Authors:  Toshimasa Yamauchi; Yasunori Nio; Toshiyuki Maki; Masaki Kobayashi; Takeshi Takazawa; Masato Iwabu; Miki Okada-Iwabu; Sachiko Kawamoto; Naoto Kubota; Tetsuya Kubota; Yusuke Ito; Junji Kamon; Atsushi Tsuchida; Katsuyoshi Kumagai; Hideki Kozono; Yusuke Hada; Hitomi Ogata; Kumpei Tokuyama; Masaki Tsunoda; Tomohiro Ide; Kouji Murakami; Motoharu Awazawa; Iseki Takamoto; Philippe Froguel; Kazuo Hara; Kazuyuki Tobe; Ryozo Nagai; Kohjiro Ueki; Takashi Kadowaki
Journal:  Nat Med       Date:  2007-02-01       Impact factor: 53.440

3.  Opposing effects of adiponectin receptors 1 and 2 on energy metabolism.

Authors:  Mikael Bjursell; Andrea Ahnmark; Mohammad Bohlooly-Y; Lena William-Olsson; Magdalena Rhedin; Xiao-Rong Peng; Karolina Ploj; Anna-Karin Gerdin; Gunnel Arnerup; Anders Elmgren; Anna-Lena Berg; Jan Oscarsson; Daniel Lindén
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

Review 4.  The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.

Authors:  John Paul SanGiovanni; Emily Y Chew
Journal:  Prog Retin Eye Res       Date:  2005-01       Impact factor: 21.198

5.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

6.  Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots.

Authors:  Maria S Rasmussen; Aina S Lihn; Steen B Pedersen; Jens M Bruun; Mads Rasmussen; Bjørn Richelsen
Journal:  Obesity (Silver Spring)       Date:  2006-01       Impact factor: 5.002

7.  Plasma lipid abnormalities in the miniature poodle with progressive rod-cone degeneration.

Authors:  R E Anderson; M B Maude; R A Alvarez; G M Acland; G D Aguirre
Journal:  Exp Eye Res       Date:  1991-03       Impact factor: 3.467

8.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.

Authors:  J Fruebis; T S Tsao; S Javorschi; D Ebbets-Reed; M R Erickson; F T Yen; B E Bihain; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

9.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  21 in total

1.  Investigating the disease association of USH2A p.C759F variant by leveraging large retinitis pigmentosa cohort data.

Authors:  Mariana DuPont; Evan M Jones; Mingchu Xu; Rui Chen
Journal:  Ophthalmic Genet       Date:  2017-12-28       Impact factor: 1.803

Review 2.  Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Authors:  Muhammad Umar Ali; Muhammad Saif Ur Rahman; Jiang Cao; Ping Xi Yuan
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

3.  CEP78 is mutated in a distinct type of Usher syndrome.

Authors:  Qing Fu; Mingchu Xu; Xue Chen; Xunlun Sheng; Zhisheng Yuan; Yani Liu; Huajin Li; Zixi Sun; Huiping Li; Lizhu Yang; Keqing Wang; Fangxia Zhang; Yumei Li; Chen Zhao; Ruifang Sui; Rui Chen
Journal:  J Med Genet       Date:  2016-09-14       Impact factor: 6.318

4.  A mutation in ADIPOR1 causes nonsyndromic autosomal dominant retinitis pigmentosa.

Authors:  Jinlu Zhang; Changguan Wang; Yan Shen; Ningning Chen; Likun Wang; Ling Liang; Tong Guo; Xiaobei Yin; Zhizhong Ma; Bo Zhang; Liping Yang
Journal:  Hum Genet       Date:  2016-09-21       Impact factor: 4.132

5.  ADIPOR1 deficiency-induced suppression of retinal ELOVL2 and docosahexaenoic acid levels during photoreceptor degeneration and visual loss.

Authors:  Hideto Osada; Eriko Toda; Kohei Homma; Naymel A Guzman; Norihiro Nagai; Mamoru Ogawa; Kazuno Negishi; Makoto Arita; Kazuo Tsubota; Yoko Ozawa
Journal:  Cell Death Dis       Date:  2021-05-07       Impact factor: 8.469

6.  Next-generation sequencing-based molecular diagnosis of 35 Hispanic retinitis pigmentosa probands.

Authors:  Qi Zhang; Mingchu Xu; Jennifer D Verriotto; Yumei Li; Hui Wang; Lin Gan; Byron L Lam; Rui Chen
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

7.  Diagnosis of a mild peroxisomal phenotype with next-generation sequencing.

Authors:  Meredith J Ventura; Dianna Wheaton; Mingchu Xu; David Birch; Sara J Bowne; Lori S Sullivan; Stephen P Daiger; Annette E Whitney; Richard O Jones; Ann B Moser; Rui Chen; Michael F Wangler
Journal:  Mol Genet Metab Rep       Date:  2016-11-11

Review 8.  Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection.

Authors:  Aram Asatryan; Nicolas G Bazan
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

9.  The phenotypic variability of HK1-associated retinal dystrophy.

Authors:  Zhisheng Yuan; Baiyu Li; Mingchu Xu; Emmanuel Y Chang; Huajin Li; Lizhu Yang; Shijing Wu; Zachry T Soens; Yumei Li; Lee-Jun C Wong; Richard A Lewis; Ruifang Sui; Rui Chen
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

10.  Neuroprotectin D1 upregulates Iduna expression and provides protection in cellular uncompensated oxidative stress and in experimental ischemic stroke.

Authors:  Ludmila Belayev; Pranab K Mukherjee; Veronica Balaszczuk; Jorgelina M Calandria; Andre Obenaus; Larissa Khoutorova; Sung-Ha Hong; Nicolas G Bazan
Journal:  Cell Death Differ       Date:  2017-04-21       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.